Q1 2024 Holdings
Filed 2024-05-15 | 35 holdings | $641.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Neurogene Inc(NGNE) | COM | 64135M105 | $51.1M | 1,004,291 | 8.0% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $44.7M | 1,128,499 | 7.0% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $39.3M | 2,620,545 | 6.1% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $35.6M | 2,488,483 | 5.5% |
| Evolus Inc(EOLS) | COM | 30052C107 | $34.3M | 2,450,000 | 5.3% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $27.6M | 1,851,864 | 4.3% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $26.6M | 400,000 | 4.1% |
| Aerovate Therapeutics Inc | COM | 008064107 | $26.2M | 887,690 | 4.1% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $23.4M | 1,335,000 | 3.6% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $22.0M | 976,981 | 3.4% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $21.4M | 8,000,000 | 3.3% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $21.0M | 775,585 | 3.3% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $20.9M | 300,000 | 3.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $19.6M | 456,148 | 3.1% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $18.8M | 2,000,000 | 2.9% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $18.8M | 625,000 | 2.9% |
| Outlook Therapeutics Inc(OTLK) | COM | 69012T305 | $17.7M | 1,480,000 | 2.8% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $17.6M | 1,495,500 | 2.7% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $15.7M | 1,728,723 | 2.5% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $15.7M | 1,264,920 | 2.4% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $14.2M | 202,202 | 2.2% |
| Optinose Inc | COM | 68404V100 | $12.8M | 8,786,318 | 2.0% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $12.0M | 407,550 | 1.9% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $10.4M | 150,000 | 1.6% |
| Merus N V | COM | N5749R100 | $10.1M | 223,288 | 1.6% |
| Vistagen Therapeutics Inc(VTGN) | COM | 92840H400 | $9.8M | 1,858,735 | 1.5% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $8.6M | 1,309,975 | 1.3% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $7.5M | 115,000 | 1.2% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $7.4M | 1,166,667 | 1.2% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $7.1M | 1,343,628 | 1.1% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $7.1M | 2,757,740 | 1.1% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $5.2M | 500,000 | 0.8% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $4.7M | 125,000 | 0.7% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $3.7M | 150,000 | 0.6% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $2.9M | 71,113 | 0.5% |